XML 58 R44.htm IDEA: XBRL DOCUMENT v3.6.0.2
Income Taxes - Schedule of Gross Deferred Tax Asset and Related Valuation Allowance (Detail) - USD ($)
Dec. 31, 2016
Dec. 31, 2015
Deferred tax assets:    
Net operating loss carryforward $ 34,451,814 $ 24,745,536
Capitalized start-up costs 2,708,479 2,986,272
Patent amortization 216,203 238,378
Research and orphan drug credits 14,988,522 10,110,590
Deferred rent 123,744 96,107
Deferred compensation 2,107,964 1,206,920
Other 70,511 52,985
Total gross deferred tax assets 54,667,237 39,436,788
Valuation allowance $ (54,667,237) $ (39,436,788)